Evidence map›Paper›PMID 42132484›Full record

ArticleDrug and alcohol review2026

Closing the Gap Between Evidence and Action: Lessons From a Dramatic Increase in Access to Alcohol.

Norman Giesbrecht, Elizabeth K Farkouh

Abstract read
In one paragraph

Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Norman GiesbrechtCentre for Addiction and Mental Health, Institute for Mental Health Policy Research, Toronto, Ontario, Canada.ORCID 0009-0006-9828-8808
Elizabeth K FarkouhBrigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol is a leading cause of death, disability, disease, trauma and social problems. In Canada, alcohol consumption is associated with 17,000 deaths annually, with costs from alcohol exceeding revenues in each jurisdiction. Leading health organisations point to policies shown to be effective in reducing alcohol harms. Yet there is a substantial and growing gap between evidence of effective policies to reduce alcohol harms and actual policies being implemented in Canada and elsewhere. This commentary critically examines one such example: the Ontario government's 2023 decision to significantly expand off-premise alcohol sales, involving up to 8500 new off-premise outlets (+290%). There were several ways in which this decision neglected public health. First, both international and Canadian-based research demonstrates that greater physical access to alcohol is associated with increased chronic disease, acute harms and deaths. However, this publicly available evidence did not appear to inform the Ontario provincial government's plans to dramatically increase alcohol availability, and the government did not appear to conduct a priori estimates of health and social impacts. Second, despite concerns from leading public health associations, the plan was not modified. Finally, the plan proceeded with minimal mitigation interventions and without an evaluation protocol. This illustrative case of evidence-neglect in public health policy can inform policymaking in other jurisdictions. Governments considering changes to alcohol policies should utilise available evidence to conduct an a priori assessment of potential risks and benefits, consult with relevant public health stakeholders, enact a robust, multi-dimensional mitigation plan, and implement an objective and comprehensive evaluation protocol.

Indexed as

Alcohol DrinkingAlcoholic BeveragesCommerceHealth PolicyPublic HealthCanadaDrinking EstablishmentsHumansOntarioPolicy Makingalcohol availabilityalcohol policyCanadamitigation

Identifiers

PMID42132484
PMCPMC13175009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.